Nr 546 nr546 week 7 Study guides, Class notes & Summaries

NR 546 Week 1-7 Quiz’s | Midterm Exam Questions With Answers and Rationales 2024. In order to provide feedback on the weekly quizzes, I will provide rationale statements for the quiz questions. You will note that there are more than 5 listed this is because the quiz testbank is larger than 5 questions and the additional information can help you prepare for the final and direct your study.  The amygdala is associated with anxiety and perception of odors.  The hippocampus is involved...

NR 546 Week 1-7 Quiz’s | Midterm Exam With Answers and Rationales (Verified ). Hello NR546 students, here are some clinical pearls and quiz bank rationales for you.  G protein linked systems, one of the signal transduction cascades, pass the message from a first receptor to a second messenger .  Glutamate is an excitatory neurotransmitter. (NEI glutamate video- the glutamate sisters)  CYP 3A4 is one of the 5 most important NT which include CYP 1A2, 2D6, 2C9, 2C19, 3A4. Dosing a...

Midterm Exam: NR546/ NR 546 (NEW Update 2024/ 2025) Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner Review |Weeks 1-4 | Questions and Verified Answers| 100% Correct- Chamberlain QUESTION Haloperidol, ziprasidone, and olanzapine Answer: increased risk of CVA, cognitive decline, and death in older adults with dementia and dementia related psychosis QUESTION aripiprazole black box warning Answer: medication with increased risk of suicide in...

NR 546 WEEK 7 ADHD Medication Table (Updated). Methylphenidate (D/L) (Concerta, Ritalin) -Dopamine, norepinephrine inhibitor and releaser (DNRIRe), stimulant, FDA approved for ADHD in children and adults (ages vary based on formulations), narcolepsy. Off-label for treatmentresistant depression. Enhancement DA and NE in certain areas of the brain (dorsolateral prefrontal cortex, medial prefrontal cortex). Primary target symptoms: concentration, attention span, motor hyperactivity,...

NR 546 WEEK 7 ADHD Medication Table. Drug Name (include if IR, XR, ODT, LA) Indication (include approved ages) Neurotransmitter(s) Affected Target Symptoms Short-acting, intermediateacting or long-acting. Duration of action, peak (if noted) Notable side effects /Patient education instructions Methylphenidate (D/L) (Concerta, Ritalin) -Dopamine, norepinephrine inhibitor and releaser (DNRIRe), stimulant, FDA approved for ADHD in children and adults (ages vary based on formulatio...

NR546 | NR 546 Week 7 | Psychopharmacology for the Psychiatric | Study Guide 2024 Guide NR546 | NR 546 Week 7 | Psychopharmacology for the Psychiatric | Study Guide 2024 Guide

Final Exam: NR546 / NR 546 (Latest Update 2024 / 2025) Advanced Pharmacology Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner Review | Complete Guide with Questions and Verified Answers | 100% Correct - Chamberlain Q: SSRI MOA inhibit 5HT reuptake first line of treatment for depression Q: SSRI s/e Answer: 7 S's of SSRIs 1.Stomach l dysfunction onin syndrome difficulties dal thoughts s (weight) Q: serotonin s/e Answer: head, red, fed head = decreased anxiety, impulsivity, ...

Final Exam: NR546/ NR 546 (Latest Update 2024/ 2025) Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner Review| Complete Guide with Questions and Verified Answers| 100% Correct- Chamberlain Q: SSRI MOA inhibit 5HT reuptake first line of treatment for depression Q: SSRI s/e Answer: 7 S's of SSRIs 1.Stomach l dysfunction onin syndrome difficulties dal thoughts s (weight) Q: serotonin s/e Answer: head, red, fed head = decreased anxiety, impul...

Final Exam: NR546 / NR 546 (Latest Update 2024 / 2025) Advanced Pharmacology Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner Guide | Weeks 5 - 8 Covered | Questions and Verified Answer s| 100% Correct - Chamberlain Q: Medication Management SSRI-Selective Serotonin Reuptake Inhibitors *Inhibit 5 HT reuptake SNRI-Serotonin Norepinephrine Reuptake Inhibitors *inhibit 5-HT reuptake *inhibit NE reuptake (increase energy, focus) *increase DA in prefrontal cortex (increase cogni...